Rossiiskii Oftal'mologicheskii Zhurnal

Aims & Scope

Russian Ophthalmological Journal is a major Russian periodical for ophthalmologists and vision professionals in this country and abroad.

The journal’s objective is to publish new results and scientific and practical achievements of Russian and international ophthalmological community aimed at exchanging ideas, knowledge, and experience, which contribute to the solution of topical ophthalmological issues worldwide.

Russian ophthalmological journal focuses on the contribution of Russian researchers and clinicians into the pathogenetic studies of eye diseases and the development of novel approaches to diagnosis and treatment of such diseases.

Importantly, the journal is an open forum for ophthalmologists from foreign countries working in the ophthalmological field.

The editorial board of the Russian ophthalmological journal makes every effort to ensure that the latest advances in international ophthalmological science are introduced into effective clinical practice as quickly as possible, so that modern high technologies of diagnosing and treating eye diseases become known and accessible to any ophthalmological centers, clinics and hospitals even if they operate very far from capital cities in Russia and abroad.

The Russian Ophthalmological Journal is widely and freely distributed among Russian ophthalmologists, so that it is easily accessible to anyone interested in the field.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A modern classification of asthenopias: clinical forms and stages

  Citation: 22

  Authors: O.V., E.P., E.N., V.V., V.V.

• An account of retinal microvascular changes in diabetes acquired by OCTangiography

  Citation: 21

  Authors: V.V., T.D., V.A.

• A strategically oriented conception of optical prevention of myopia onset and progression

  Citation: 19

  Authors: E. P., O. V., G. A., S. V., N. A., N. V.

• Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice

  Citation: 18

  Authors: R. R.

• Myopia predictors as a starting point for active prevention of myopia development

  Citation: 16

  Authors: E.P., O.V., N.A., R.A., A.S.

• Aflibercept for the therapy of retinal diseases. A review of clinical studies

  Citation: 14

  Authors: T.D., O.V.

• Ophthalmological aspects of coronavirus infections

  Citation: 13

  Authors: V. V., T. N., E. K.

• Interaction of accommodative and subjective diagnostic criteria of accommodation disorders

  Citation: 11

  Authors: M. V., V. V.

• Modeling the atrophy of retinal pigment epithelium

  Citation: 11

  Authors: N. V., V. V., P. A., A. G., O. A., M. V., A. M.

• Possibilities of color Duplex Imaging in the diagnosis of ocular vascular pathology

  Citation: 11

  Authors: T.N., M.S., K.A., K.V.